Arcus Capital Partners’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
Other funds holding EXEL
FCM
Arcus Capital Partners's EXEL Position: Q2 2026 in Review
Arcus Capital Partners reduced its Exelixis (EXEL) stake by 3.6% in Q2 2026, selling an estimated $10.4K and leaving 5,662 shares worth $308K. The position accounts for 0.13% of the portfolio, ranked #89.
Arcus Capital Partners first reported a position in EXEL in Q3 2025 and has held it in 4 quarters since. The position peaked at $330K in Q4 2025. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.
- Arcus Capital Partners held 5,662 shares of Exelixis worth $308K as of Q2 2026.
- Arcus Capital Partners sold 214 Exelixis shares in Q2 2026, an estimated $10.4K.
- Exelixis made up 0.13% of Arcus Capital Partners's portfolio in Q2 2026, its #89 holding.
- Arcus Capital Partners first reported a position in Exelixis in Q3 2025 and has held it in 4 quarters since.
- Arcus Capital Partners's Exelixis position peaked at $330K in Q4 2025.
- 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.
Based on Arcus Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.